| Ole Health | |
|
1101 B Gale Wilson Blvd Ste 101c Fairfield CA 94533-3771 | |
| (707) 254-1770 | |
| Not Available |
| Full Name | Ole Health |
|---|---|
| Speciality | Clinic/Center |
| Location | 1101 B Gale Wilson Blvd Ste 101c, Fairfield, California |
| Authorized Official Name and Position | Alicia Hardy (EXECUTIVE CHIEF OFFICER) |
| Authorized Official Contact | 7072541774 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ole Health 1141 Pear Tree Ln Ste 100 Napa CA 94558-6485 Ph: (707) 254-1770 | Ole Health 1101 B Gale Wilson Blvd Ste 101c Fairfield CA 94533-3771 Ph: (707) 254-1770 |
| NPI Number | 1316429558 |
|---|---|
| Provider Enumeration Date | 09/04/2018 |
| Last Update Date | 11/15/2019 |
| Medicare PECOS PAC ID | 7315934767 |
|---|---|
| Medicare Enrollment ID | O20200421001314 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.
One Monday in February, 65-year-old Karen Endicott-Coyan gripped the wheel of her black 2014 Ford Taurus with both hands as she made the hour-long drive from her farm near Fort Scott to Chanute.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Stuttering is a debilitating condition that can change the course of people's lives. "When I thought about career options, I would think, well, I'd like to do this, but I can't because of my speech so I'll have to do something else," said Jacob, a science student at UTS. "In social situations, I wouldn't introduce myself."
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316429558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (California) | Primary |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.
One Monday in February, 65-year-old Karen Endicott-Coyan gripped the wheel of her black 2014 Ford Taurus with both hands as she made the hour-long drive from her farm near Fort Scott to Chanute.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Stuttering is a debilitating condition that can change the course of people's lives. "When I thought about career options, I would think, well, I'd like to do this, but I can't because of my speech so I'll have to do something else," said Jacob, a science student at UTS. "In social situations, I wouldn't introduce myself."
› Verified 9 days ago
Gurpreet S. Dhugga Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5030 Business Center Dr, Ste 130, Fairfield, CA 94534 Phone: 707-864-1056 | |
County Of Solano Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2101 Courage Dr, Fairfield, CA 94533 Phone: 707-784-2010 Fax: 707-435-2032 | |
Humu Health Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1261 Travis Blvd Ste 375, Fairfield, CA 94533 Phone: 707-763-2515 | |
Sutter Regional Medical Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2720 Low Ct, Fairfield, CA 94534 Phone: 707-428-2731 Fax: 707-428-2740 | |
Jeannette Peterson Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1261 Travis Blvd, Suite 100, Fairfield, CA 94533 Phone: 707-422-0543 Fax: 707-422-0549 | |
County Of Solano Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 275 Beck Ave, Fairfield, CA 94533 Phone: 707-784-8400 Fax: 707-421-3207 | |
Davita Renal Specialists Of California Medical Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 650 Empire St, Suite A, Fairfield, CA 94533 Phone: 707-426-5407 Fax: 707-426-6376 |